Loading Events

Upcoming Events › Deadlines

Events Search and Views Navigation

Event Views Navigation

April 2020

Deadline for NIAID BAA Proposals: Development of Radiation/Nuclear Medical Countermeasures

April 9
Global Biodefense Calendar

Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1 This research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. It supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading to a reduction in radiation-associated morbidities and mortalities. Due Date: April 9, 2020, by 3 p.m. Eastern Time Read more about this opportunity in Funding News.

Find out more »

Deadline for NIAID BAA Proposals: Therapeutic Products for Biodefense, AMR Infections, and Emerging Infectious Diseases

April 9
Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 , including optimization, preclinical (investigational new drug-enabling), and clinical trials that include Phase I and Phase II studies. Due Date: April 9, 2020, by 3 p.m. Eastern Time Read more on…

Find out more »

Deadline for NIAID BAA Proposals: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

April 9
Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp., Pseudomonas aeruginosa, Francisella tularensis, Yersinia pestis, and E. coli, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses (e.g., Eastern Equine Encephalitis) and bunyaviruses (e.g., Rift Valley Fever Virus). Due Date: April 9, 2020, by 3 p.m. Eastern Time Learn more about this opportunity…

Find out more »

Deadline for NIAID BAA Proposals: Advanced Development of Diagnostics for Biothreats and EID

April 9
Global Biodefense Calendar

HHS-NIH-NIAID-BAA2020-1 Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness. Number of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up to $2 million for the non-severable base work across all contracts (direct and indirect costs combined). Due Date: April 9, 2020, by 3 p.m. Eastern Time…

Find out more »

Quickfire Challenge Applications Due: JLABS Pediatric Influenza Innovations

April 24
Global Biodefense Calendar

Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies. The submission deadline is 24 April 2020. Please visit the JLABS website for more information.

Find out more »

EZ BAA Deadline: Novel Coronavirus Rapid Diagnostic

April 30
Global Biodefense Calendar

Under this EZ BAA, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, will review concise abstract submissions for development funding of 2019-nCoV molecular diagnostics. The diagnostics must utilize platforms already cleared by the U.S. Food and Drug Administration, with a viable plan to meet requirements for the FDA to consider Emergency Use Authorization (EUA) within 12 weeks of an award. This area of interest will be open for…

Find out more »

May 2020

Applications Due: Global Health Security Partnership Lab Capacity Grants

May 4
Global Biodefense Calendar

This CDC Center for Global Health is working to partner and build laboratory and biosurveillance capacity globally under this funding effort (CDC-RFA-GH20-2109) to reduce the risks of emerging infectious diseases and strengthen public health response to outbreaks. Grants are available to all types of organizations (government, academic, nonprofit, industry, etc.). Supported activities include: Assessing capacity of national reference, provincial and district labs Identifying lab system focal points, defining a tiered services structure Developing and implementing strategic lab plans Mapping regional…

Find out more »

July 2020

Deadline for NIBIB Technology Accelerator Challenge: Handheld Diagnostics

July 2
Global Biodefense Calendar

NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health This challenge seeks designs for non-invasive technology platforms to diagnose sickle cell disease, malaria, and anemia. While not constrained to any specific technology, the inspiration for this challenge comes from the widespread availability of mobile phones and the potential for mobile phone-linked sensor technologies to non-invasively detect changes in the blood and vasculature associated with these treatable diseases. Key Dates Release Date: January 31, 2020 Estimated Competition Opening Date: March…

Find out more »

February 2021

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

February 6, 2021
Global Biodefense Calendar

A Notice of Special Interest (NOSI) was issued on Feb. 6, 2020 to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV) jointly by National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of General Medical Sciences (NIGMS). Applications will be accepted on a rolling basis from February 6, 2020 through February 6, 2021 by 5:00 PM local time of the applicant organization. This NOSI expires on February 6, 2021. An application submitted in response to…

Find out more »
+ Export Events